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Background
Dutch type periodic fever (DPF) is a hereditary fever syn-
drome caused by a deficiency of the enzyme mevalonate
kinase (MVK). The most of the patients have been
reported from France and Netherlands.
Case report
A seven-month-old Turkish boy was consulted to Pediat-
ric Rheumatologist for evaluation of periodic fever. He
experienced fever episodes since two months following
birth once or twice a month, lasting for 2–4 days. He had
been hospitalized for 4 times to identify the etiology of
fever. Conjunctivitis without periorbital edema and
diarrhea accompanied almost every attack. In one of these
attacks, he had a unilateral cervical lymphadenopathy. He
had erythematous macules at one fever episode. In every
attack CRP was extremely elevated. His uncle had chronic
renal insufficiency of unknown etiology. FMF was sus-
pected. The heterozygous V726A variant of MEFV was
detected. He was put on colchicine; however he did not
respond despite 6 months of therapy. His serum IgD lev-
els were normal during attacks. Association of lymphade-
nopathy and diarrhea with recurrent fevers considered
DPF. Genetic analysis revealed two mutations on MVK
gene. He was put on simvastatin 5 mg/day. The 4 months
course of simvastatin therapy failed to reduce the attacks.
Conclusion
This is the third case of DPF reported from Turkey. The
presented case shows a rare coincidence of MVK gene with
MEFV mutation. The first case also had a heterozygous
MEFV mutation and did not respond to simvastatin [1].
The presence of MEFV mutation in DPF might be a poor
prognostic sign regarding the response to therapy.
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